|
Sections
Agriculture
Applied sciences
Arts
Belief
Business
Chronology
Culture
Education
Environment
Geography
Health
History
Humanities
Language
Law
Life
Mathematics
Nature
People
Politics
Science
Society
Technology
|
| |
Pittsburgh Business Times
Fri, 24 May 2013 10:53:34 -0700
U.S. Renal Care has agreed to pay $7.3 million to resolve allegations of overbilling Medicare for a drug used to treat anemia, the U.S. Department of Justice announced on Tuesday. The alleged violations of the False Claims Act occurred at Dialysis Corp ...
| | |
TheHeart.Org
Fri, 24 May 2013 08:00:42 -0700
Paris, France - Twelve-month results from the EnlighHTN-1 trial testing the EnlighHTN multielectrode renal-denervation catheter (St Jude Medical) show continued safety and durable efficacy of the BP-lowering effects in this small, first-in-human study.
| | |
4-traders (press release)
Fri, 24 May 2013 12:30:20 -0700
George Tidmarsh, M.D., Ph.D., President and Chief Executive Officer of La Jolla, said, "This retrospective analysis emphasizes the fact that GCS-100 treatment in patients with reduced renal function have improvement in estimated glomerular filtration rate.
| | |
Healio
Fri, 24 May 2013 03:07:33 -0700
According to John A. Ormiston, MD, with Mercy Angiography, Auckland, New Zealand, who presented the findings here, the OneShot renal denervation system (Covidien) requires a single 2-minute ablation per artery. The device also features cooling by ...
| | |
Sacramento Bee
Wed, 22 May 2013 04:57:17 -0700
BALTIMORE, May 21, 2013 -- /PRNewswire/ -- U.S. Renal Care has agreed to pay $7.3 million to the federal government to settle a whistleblower lawsuit brought by a nurse that alleged a company U.S. Renal Care acquired, Dialysis Corporation of America ...
| | |
MarketWatch (press release)
Thu, 23 May 2013 03:01:04 -0700
MINNEAPOLIS - May 23, 2013 - Medtronic, Inc. (NYSE:MDT) , today announced it has finished randomizing Symplicity HTN-3, the company's pivotal U.S. clinical trial of the Symplicity(TM) renal denervation system for treatment-resistant hypertension. Renal ...
| | |
OncLive
Wed, 22 May 2013 07:34:45 -0700
Renal cell carcinoma accounts for 2% to 3% of adult malignancies and is the third most common urologic malignancy after prostate and bladder cancer. Over the last 65 years, the rate of diagnosis has increased by approximately 2% per year as the use of ...
| | |
Renal Business Today
Wed, 22 May 2013 15:25:27 -0700
LAKEWOOD, Colo.—Renal Ventures Management announced that Greg Meadows has joined the company as the president and CEO of RV Infusion Partners, which is a subsidiary of Renal Ventures Management. Meadows comes to Renal Ventures after ...
|
Oops, we seem to be having trouble contacting Twitter
|
|
You can talk about Renal with people all over the world in our discussions.
|
